Evidence map›Paper›PMID 31334107›Full record

ReviewFrontiers in oncology2019

Global Investigations of

Seul A Lee, Fang Liu, Stephen M Riordan, Cheok S Lee, Li Zhang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 3 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 3 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Topic Application of the ProbioticFrontiers in cellular and infection microbiology · 2020
    Trial
  5. Article
  6. Review
  7. Article
  8. MedComm · 2025
    Review
  9. Article
  10. Article
  11. Prognosis in stage II colon cancer: Expanding the horizons of risk factors.World journal of gastrointestinal oncology · 2025
    Article
  12. Potential and application ofFrontiers in microbiology · 2025
    Article
  13. The rise and evolving role ofCurrent research in microbial sciences · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Cancers · 2023
    Review
  19. The oral-gut-circulatory axis: from homeostasis to colon cancer.Frontiers in cellular and infection microbiology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Seul A LeeSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.
Fang LiuSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.
Stephen M RiordanGastrointestinal and Liver Unit, Prince of Wales Hospital, University of New South Wales, Sydney, NSW, Australia.
Cheok S LeeDiscipline of Pathology, School of Medicine, Western Sydney University, Sydney, NSW, Australia.
Li ZhangSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.
UNSW Sydney · AUPrince of Wales Hospital · AUUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is the third most prevalent cancer and second in terms of mortality. Emerging evidence from recent studies suggests a potential role of

Indexed as

colorectal cancerCRCF. nucleatumFusobacterium nucleatumtumorigenic mechanisms

Identifiers

PMID31334107
PMCPMC6618585
OpenAlexW2954746300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.